BALYASNY ASSET MANAGEMENT L.P. - AKEBIA THERAPEUTICS INC ownership

AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 166 filers reported holding AKEBIA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.12 and the average weighting 0.0%.

Quarter-by-quarter ownership
BALYASNY ASSET MANAGEMENT L.P. ownership history of AKEBIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$13,000
+44.4%
40,606
+64.8%
0.00%
Q2 2022$9,000
-81.2%
24,634
+30.0%
0.00%
Q3 2020$48,000
-61.9%
18,947
+49.8%
0.00%
-100.0%
Q2 2018$126,000
-60.0%
12,645
-61.8%
0.00%0.0%
Q1 2018$315,000
+76.0%
33,099
+174.7%
0.00%0.0%
Q4 2017$179,000
-97.9%
12,049
-98.5%
0.00%
-98.1%
Q2 2015$8,524,000
+453.1%
828,357
+497.3%
0.05%
+333.3%
Q1 2015$1,541,000
-42.2%
138,676
-39.4%
0.01%
-50.0%
Q4 2014$2,665,000228,9340.02%
Other shareholders
AKEBIA THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Consonance Capital Management LP 7,031,283$95,485,0005.72%
GREAT POINT PARTNERS LLC 3,510,073$47,667,0003.81%
Logos Global Management LP 1,200,000$16,296,0003.26%
DAFNA Capital Management LLC 762,666$10,357,0002.99%
Baupost Group 15,000,000$203,700,0002.54%
Nantahala Capital Management 6,101,111$82,853,0002.50%
Abrams Capital Management 5,656,462$76,815,0002.48%
Novo Holdings A/S 1,987,506$26,990,0001.74%
Stanley-Laman Group, Ltd. 316,933$4,304,0001.04%
Integral Health Asset Management, LLC 250,000$3,395,0001.02%
View complete list of AKEBIA THERAPEUTICS INC shareholders